InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Haller Julia A, Director. Director active across 2 companies, notably Bristol Myers Squibb Co. In total, 9 disclosures have been logged. History available since 3 June 2021. The latest transaction was disclosed on 16 June 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
9 of 9 declarations
Julia A. Haller is a Board Member at Bristol Myers Squibb Co and Eyenovia, Inc. She is involved in overseeing the operations of these companies and formulating strategies aimed at enhancing performance. Her expertise in the pharmaceutical sector is a valuable asset.